SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (13705)2/27/2021 5:07:10 PM
From: Investor2  Read Replies (1) | Respond to of 22883
 
Drug used to treat lice and scabies drug could cut Covid deaths by up to 75%, research suggests
New study suggests ivermectin cuts Covid infections by around 75 per cent
More than 30 trials globally found the drug caused improvements in treatment
The study is set to be published in the US journal Frontiers of Pharmacology
What do you think the odds are of actually implementing ivermectin as a pre-hospitalization or prophylactical Covid-19 treatment in the United States, even if it works?

Best wishes,

I2


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News